X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (471) 471
Newspaper Article (196) 196
Book Review (137) 137
Publication (73) 73
Newsletter (29) 29
Magazine Article (20) 20
Book Chapter (9) 9
Conference Proceeding (5) 5
Trade Publication Article (4) 4
Web Resource (4) 4
Report (3) 3
Government Document (2) 2
Reference (2) 2
Transcript (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ebola virus (506) 506
vaccines (357) 357
index medicus (337) 337
humans (292) 292
epidemics (201) 201
ebola virus infections (171) 171
viruses (159) 159
public health (148) 148
infectious diseases (143) 143
animals (142) 142
clinical trials (135) 135
hemorrhagic fever, ebola - prevention & control (131) 131
ebola (104) 104
health aspects (104) 104
immunization (102) 102
virus diseases (101) 101
medical research (99) 99
female (86) 86
immunology (85) 85
male (80) 80
studies (80) 80
infection (79) 79
research (76) 76
hemorrhagic fever, ebola - epidemiology (74) 74
nonhuman-primates (74) 74
infections (73) 73
hemorrhagic-fever (72) 72
disease (70) 70
ebola vaccines - immunology (70) 70
prevention (70) 70
vaccination (68) 68
ebolavirus - immunology (67) 67
virology (65) 65
adult (55) 55
mortality (55) 55
vaccine (55) 55
genomes (53) 53
analysis (52) 52
microbiology (52) 52
ebola vaccines - administration & dosage (51) 51
article (50) 50
medicine (49) 49
hemorrhagic fever, ebola - immunology (48) 48
medicine, experimental (47) 47
abridged index medicus (46) 46
ebola vaccines - adverse effects (46) 46
medicine, general & internal (46) 46
care and treatment (45) 45
middle aged (45) 45
meningitis (43) 43
fever (42) 42
viral diseases (41) 41
ebola-virus (40) 40
editing (40) 40
hemorrhagic fever, ebola - virology (40) 40
medicine, research & experimental (40) 40
antigens (38) 38
hemorrhagic fever, ebola - drug therapy (38) 38
pharmacology & pharmacy (38) 38
young adult (38) 38
adenoviruses (37) 37
proteins (37) 37
disease outbreaks (36) 36
ebolavirus - genetics (36) 36
ethics (36) 36
outbreaks (36) 36
glycoproteins (35) 35
hemorrhagic fever, ebola - therapy (35) 35
mice (35) 35
disease models, animal (34) 34
safety (34) 34
fatalities (33) 33
pathogens (33) 33
pharmaceutical industry (33) 33
antibodies, viral - blood (32) 32
africa, western - epidemiology (31) 31
antiviral agents (31) 31
epidemiology (31) 31
product development (31) 31
usage (31) 31
genetic vectors (30) 30
immunogenicity (30) 30
adolescent (29) 29
outbreak (29) 29
health care (28) 28
immune response (28) 28
research article (28) 28
disease control (27) 27
ebolavirus (27) 27
marburg virus (27) 27
tropical diseases (27) 27
viral infections (27) 27
antiviral agents - therapeutic use (26) 26
hospitals (26) 26
pathogenesis (26) 26
protects nonhuman-primates (26) 26
ebolavirus - drug effects (25) 25
infectious disease (25) 25
internal medicine (25) 25
medicine and health sciences (25) 25
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 10, pp. 1156 - 1166
Summary Background Safe and effective vaccines against Ebola could prevent or control outbreaks. The safe use of replication-competent vaccines requires a... 
Infectious Disease | INFECTIOUS DISEASES | MARBURG VIRUS | ACTIVATION | DUCK RUBELLA VACCINE | IMMUNE-RESPONSES | PROTECTS NONHUMAN-PRIMATES | VESICULAR STOMATITIS | GLYCOPROTEINS | INFECTION | FEVER | AGE | Hemorrhagic Fever, Ebola - prevention & control | Vasculitis - epidemiology | Arthritis - epidemiology | Humans | Middle Aged | Vasculitis - pathology | Antigens, Viral - genetics | Male | Vaccination - adverse effects | Vaccines, Synthetic - immunology | Ebolavirus - genetics | Antibodies, Viral - blood | Dermatitis - epidemiology | Drug Carriers | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Arthritis - chemically induced | Vaccination - methods | Vaccines, Synthetic - adverse effects | Vesiculovirus - genetics | Adult | Ebola Vaccines - immunology | Female | Vasculitis - chemically induced | Placebos - administration & dosage | Double-Blind Method | Arthritis - pathology | Ebola Vaccines - administration & dosage | Ebola Vaccines - adverse effects | Switzerland | Drug-Related Side Effects and Adverse Reactions - epidemiology | Dermatitis - pathology | Adolescent | Aged | Vaccines, Synthetic - administration & dosage | Ebola virus | Hospitals | Clinical trials | Product development | Cross infection | Vaccines | Nosocomial infections | Health aspects | Epidemics | Disease | Arthritis | Dermatitis | Ankle | Wrist | Consortia | Pain | Adenoviruses | Fingers & toes | Skin | Public health | Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 04/2016, Volume 315, Issue 15, pp. 1610 - 1623
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 10, pp. 928 - 938
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2017, Volume 376, Issue 4, pp. 330 - 341
Journal Article
Journal of Virology, ISSN 0022-538X, 10/2011, Volume 85, Issue 20, pp. 10605 - 10616
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 02/2015, Volume 211, Issue 4, pp. 549 - 557
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 17, pp. 1647 - 1660
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 15, pp. 1438 - 1447
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 2010, Volume 29, Issue 2, pp. 304 - 313
Abstract Ebola virus causes irregular outbreaks of severe hemorrhagic fever in equatorial Africa. Case mortality remains high; there is no effective treatment... 
Allergy and Immunology | Filovirus vaccine | Gene-based vaccines | Adenovirus | Ebola | NONHUMAN-PRIMATES | MEDICINE, RESEARCH & EXPERIMENTAL | OF-CONCEPT | RHESUS-MONKEYS | PHASE-1 SAFETY | IMMUNOLOGY | ADENOVIRUS VECTORS | HEMORRHAGIC-FEVER | TYPE-1 GAG GENE | CANDIDATE VACCINE | INDUCED IMMUNITY | HIV-1 VACCINE | Ebola Vaccines - genetics | Hemorrhagic Fever, Ebola - prevention & control | Humans | Middle Aged | Male | Neutralization Tests | Ebolavirus - genetics | Antibodies, Viral - blood | Ebolavirus - immunology | Young Adult | Adult | Ebola Vaccines - immunology | Female | Hemorrhagic Fever, Ebola - immunology | Placebos - administration & dosage | Cytokines - immunology | Viral Envelope Proteins - genetics | Double-Blind Method | Enzyme-Linked Immunosorbent Assay | Ebola Vaccines - adverse effects | Vaccines, Attenuated - immunology | Animals | Adolescent | T-Lymphocytes - immunology | Viral Envelope Proteins - immunology | Adenoviruses, Human - genetics | Genetic Vectors | Vaccines, Attenuated - adverse effects | Antibodies, Neutralizing - blood | Vaccines, Attenuated - genetics | Ebola virus | Proteins | Clinical trials | Fatalities | Infections | Vaccines | Deoxyribonucleic acid--DNA | Index Medicus | Hemorrhagic fever | Cytokines | Mortality | Antibodies | DNA vaccines | Glycoproteins | Lymphocytes T | Immunity | Immune response (humoral) | Envelopes | Immunogenicity | Serotypes | Replication | Enzyme-linked immunosorbent assay
Journal Article